Search：
All Dates：
- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
All Rooms：
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A206
- A2-A207
- A2-A208
- A2-A213
- A2-A214
- A2-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-13 (Saturday)
A1-A (105-107)
16:30-17:30
| Interventional Oncology and Immuno-oncology for Hepatocellular Carcinoma
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:30-16:40 |
TACE and It's Combination for HCC |
Bin-Yan Zhong | Zhejiang Cancer Hospital, China |
| 2 | 16:40-16:50 |
Radioembolization: Have we reached peak technology? |
David M. Liu | University of British Columbia, Canada |
| 3 | 16:50-17:00 |
The Immunotherapy Era: Challenges and Opportunities for Interventional Oncology in the MDT of HCC |
Xiao-Dong Wang | Peking University Cancer Hospital, China |
| 4 | 17:00-17:10 |
Exploration of Noninvasive Biomarkers for Clinical Outcomes Following Interventional Therapy Combined with Systemic Treatment in Hepatocellular Carcinoma |
Zhi-Cheng Jin | Zhongda hospital, Southeast university, China |
| 5 | 17:10-17:30 |
Discussion |
A LL |
